Interv Akut Kardiol. 2004;3(4):202-204

RECURRENT SUBACUTE IN STENT THROMBOSIS - BAD LUCK?

Pavel Boček, Jan Pešek, Ivo Bernat
I. Interní klinika, kardiologické oddělení, FN Plzeň

64 years old male smoker with history of MI (anterior wall 10 years ago) was admitted to our hospital for direct PCI (chest pain lasting 5 hours, elevation of ST segment on EKG). On admission advanced heart failure indicated artificial ventilation. Direct PCI of circumflex branch (thrombotic occlusion) with implantation of 2 stents was performed. Two days later patient was transferred to the local hospital.

Two days later it was necessary to perform new direct PCI due to incoming STEMI in the same location (thrombotic reocclusion) and the other reintervention we had to perform 5 days later. All together 4 stents have been implanted, during the second reocclusion abciximab was applied. This hospitalization lasted 23 days, all complications (pneumonia and heart failure) have been treated and whole this time patient has been treated by LMWH, clopidogrel and aspirin. On the 23rd day patient was discharged. Six months later patient is feeling O. K., functional class NYHA II, ejection fraction of left ventricle has been only slightly dropped in comparison with the value on the first admission. Laboratory tests did not discover any coagulopathy or homeostasis dysbalance.

Conclusion: PCI must be done with maximal attention paid to optimalization of the technique, if it is possible the IVUS examination is preferable and if it cannot be done the high pressure post dilatation should be applied. It is extremely important carefully examine the result even in the areas surrounding stents. In the case of thrombotic occlusions pharmacotherapy should be optimized.

Keywords: acute coronary syndrome, subacute thrombosis, percutaneous coronary intervention.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Boček P, Pešek J, Bernat I. RECURRENT SUBACUTE IN STENT THROMBOSIS - BAD LUCK? Interv Akut Kardiol. 2004;3(4):202-204.
Download citation

References

  1. de Feyter PJ, De Scheerder I, van den Brand M, et al. Emergency stenting for refractory acute coronary artery occlusion during coronary angioplasty. Am J Cardiol. 1990; 66: 1147-1150. Go to original source... Go to PubMed...
  2. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987; 316: 701-706. Go to original source... Go to PubMed...
  3. Hall P, Nakamura S, Maiello L, et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation. 1996; 93: 215-222. Go to original source... Go to PubMed...
  4. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three anti-thrombotic drug regimens after coronary artery stenting. N Engl J Med. 1998; 338: 1665-1671. Go to original source... Go to PubMed...
  5. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation. 1998; 98: 1507-1603. Go to original source... Go to PubMed...
  6. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J. 1993; 126: 15-22. Go to original source... Go to PubMed...
  7. Hasdai D, Garratt KN Jr, Holmes DR, et al. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol. 1996; 28: 361-367. Go to original source... Go to PubMed...
  8. Carrozza JP Jr, Schatz RA, George CJ, et al. Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) Registry. Am J Cardiol. 1997; 80: 78K-88K. Go to original source... Go to PubMed...
  9. Sutton JM, Ellis SG, Roubin GS, et al, for the Gianturco-Roubin Intracoronary Stent Investigator Group. Major clinical events after coronary stenting: the Multicenter Registry of Acute and Elective Gianturco-Roubin Stent Placement. Circulation. 1994; 89: 1126-1137. Go to original source... Go to PubMed...
  10. EPISTENT Investigators. Randomized placebo-controlled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 1998; 352: 87-92. Go to original source... Go to PubMed...
  11. Cutlip DE, at al. Stent Thrombosis in Modern Era. Circulation 2001; 103: 1967-1971. Go to original source...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.